.
. Scope Venue Agenda Deadlines Organisers Sponsors
.
.
Practical Information
Special Issue
-
Programme
Poster presentations
Exhibitors
.

Sponsors


Ever since the word "Proteome" was introduced, scientists have embraced the field of proteomics as an exciting new way to advance discoveries.
As a biomedical research and diagnostics company, Beckman Coulter has been actively involved in protein research for decades. By combining our many technological strengths with a systems biology approach, ProteomeLab builds on our past to deliver a suite of complementary tools that are optimised for accelerating protein discovery.
Our solutions encompass virtually every aspect of the proteomics process, including: antigen identification, cellular isolation, protein fractionation, protein characterization, data evaluation and disease diagnosis
www.beckmancoulter.com/proteomelab



TECAN is a leading player in the fast growing Life Sciences supply industry that specializes in the development, production, and distribution of enabling solutions for the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. With a long history in the liquid handling and microplate processing business, Tecan is synonymous with outstanding performance, efficiency and superior technical support and service.
Using new information on the human genome, scientists are examining the complex route from genes to proteins and learning how proteins interact to create healthy cell function or disease. Proteomics promises to drive the next revolution in drug discovery. Tecan's core competencies enable us to address the three major laboratory bottlenecks in this young science: sensitivity (e.g. detecting unknown, rare proteins that could be interesting drug targets), highthroughput methods (automation) and reproducibility of results.



Founded in 1997, Geneva Bioinformatics (GeneBio) S.A. has evolved from its initial, and continuing, mandate as exclusive distributor for the renowned Swiss Institute of Bioinformatics (SIB) and emerged as a multifaceted Bioinformatics company. Through both in-house development and strategic alliances with key research institutions and companies GeneBio offers its clients original, knowledge-oriented discovery tools and solutions to further enhance proteomics-based research.



SELDI ProteinChip® Systems perform rapid Expression Difference Mapping(tm) analysis to discover novel biomarkers in disease, drug development, toxicity and theranostic studies. SELDI-assisted protein purification methods accelerate the identification of these newly discovered biomarkers while Interaction Discovery Mapping(tm) applications on the same platform enable protein-protein interaction studies.
www.ciphergen.com



Applied Biosystems provides core technologies for protein analysis such as identification, characterization, quantitation and interaction. These technologies supply advanced and integrated solutions for the various steps in the protein discovery process. These unique proteomics systems increase throughput by decreasing manual handling of samples. In addition, they increase the ability to deal with difficult or low abundance proteins and streamline the data management process, through an informatics approach (Rapid Integration Solutions) to produce valuable information. This information and knowledge can then be translated into the identification of new biological discoveries including new drug targets for the development of new therapeutics.




Waters Corporation is the world's leading supplier of high performance liquid chromatography, mass spectrometry, and thermal analysis products. Around the world Watersâ products are used by pharmaceutical, life science, industrial, environmental and food analysis, university and government scientists in research and development, quality assurance and other laboratories. Our technologies provide these customers with fundamental data on their samples. Then, by turning this analytical data into useful information, we help scientists understand the complexities of chemistry and life itself.



Dionex Corporation develops, manufactures, sells, and services chromatography and extraction systems used to separate, isolate, and identify the components of chemical mixtures. Dionex products are used extensively in the environmental, pharmaceutical, life science, biotechnology, chemical, petrochemical, power generation and electronics industries. Dionex customers include many of the world's largest companies, as well as government agencies, research institutions, and universities.
www.dionex.com



Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company's innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of distributors and OEM resellers.



Committed to accelerating the pace of drug discovery and disease research, Agilent Technologies focuses on providing solutions to critical problems in research, analysis, and process validation faced by life scientists in the biotechnology and pharmaceutical industries.
As a leading manufacturer of advanced products and instruments, Agilent is able to provide comprehensive solutions for the analysis of nucleic acids and gene expression, genotyping, protein and peptide analysis as well as drug discovery, drug development and, drug manufacturing.



PerkinElmer is a global technology leader providing products and services to customers in health sciences and other advanced technology markets that require innovation, precision and reliability. Operating through three business units - Life and Analytical Sciences, Optoelectronics, and Fluid Sciences -- PerkinElmer, Inc. provides scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and industrial markets.
www.perkinelmer.com



The creation of Shimadzu Biotech, the new strategic global business unit of Shimadzu Corporation provides a strong solutions-based platform to further biotechnology R&D.
Shimadzu Biotech integrates the robust technology and expertise from Shimadzu Corporation and its subsidiary, Kratos Analytical, to provide a seamless approach to the evolving proteomics and genomics markets. The wide range of Shimadzu Biotech's products employ technologies as diverse as DNA sequencing, high performance QIT ToF mass spectrometry and SNP genotyping.
As part of the support to both Life Science and Drug Discovery, Shimadzu Biotech has formed the Proteomics Alliance, a strategic partnership with Proteome Systems and Sigma-Aldrich. The trio of companies are working together to provide quality core products that meet the demands of protein scientists – from front-end chemicals to protein identification and informatics.



Amersham Biosciences, the life sciences business of Amersham (LSE, NYSE, OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Focusing on the importance of functional biology, we are at the forefront of drug discovery, providing the technologies to uncover, develop and produce molecular medicines. We develop technologies and products in the areas of genomics, proteomics, bioassays, protein separations and informatics. Amersham Biosciences operates globally with major research, development and production facilities in the United States, Sweden and the United Kingdom.
For more information, please visit
www.amershambiosciences.com




Merck's LIFE SCIENCE PRODUCTS Division supports the efforts of its customers in the pharmaceutical industry during the entire drug development process.
Merck's proteomics research portfolio encompasses unique products, from sample preparation to separation tools.
Through its affiliate EMD/Merck Biosciences Inc. Merck offers a broad array of products used worldwide in disease-related life sciences research. EMD/Merck Biosciences brands are leading providers for signal transduction (Calbiochem), apoptosis (Oncogene), protein expression (Novagen) and peptide synthesis (Novabiochem).
Visit us on www.merck-lsp.de and click on "Bioscience".



Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Our integrated solutions combine automated sample preparation robots, advanced mass spectrometry instrumentation, reagent kits and software for data interpretation and data mining.
Chief Chromatographic and Related Techniques Supported:
LC-MS, LC-MS(n), 2D nanoLC-MS(n), LC-NMR-MS, CE-MS, CE MS(n),
LC-MALDI-TOF MS, LC-MALDI TOF/TOF.
Our integrated systems are tailored for high-throughput protein and DNA analysis, drug discovery and development, metabolic profiling, molecular diagnostics, food analysis and general chemical research. The Bruker Daltonics Group currently employs about 650 people worldwide. Development and production sites are situated in the US and Germany. An international network of Sales, Applications and Service centers and qualified distributors supports our worldwide activities.

Visit us on www.bdal.de/



© Swiss Proteomics Society

FontisMedia SA